Biography
Professor Jianjun Liu is currently the Acting Executive Director and Distinguished Institute Fellow at the Genome Institute of Singapore (GIS) and Professor at the Yong Loo Lin School of Medicine, National University of Singapore.
Prof Liu’s main research interest is to understand the genetic susceptibility of human diseases. Focusing on Asian populations, he has pursued collaborative research on discovering genetic variants that influence disease susceptibility, progression and treatment outcome. Prof Liu’s research covers diverse disease phenotypes, including cancers, autoimmune/inflammatory diseases, neurological and neuropsychiatric disorders, metabolic and cardiovascular diseases, and infectious diseases. Prof Liu’s research efforts have pioneered genome-wide association studies of complex diseases and adverse drug reaction in Asian population and contributed to understanding the genetic architecture of Asian populations.
By publishing over 470 peer reviewed papers with over 49,000 citations (H-index = 95, Web of Science 2022), Prof Liu has been well recognized by international research community and was named by Thomson Reuters as one of “The World’s Most Influential Scientific Minds” (top 1% of scientists with the highest number of citations globally) in 2015. For his contributions to the genetics of Asian populations, Prof Liu was awarded the “Chen Young Investigator Award” by the Human Genome Organization (HUGO) in 2011 and the “President’s Science Award” of Singapore in 2020.